Literature DB >> 17849073

Torsades de Pointes ventricular tachycardia in a pediatric patient treated with fluconazole.

Jesse J Esch1, Michal J Kantoch.   

Abstract

Fluconazole is an antifungal medication that has been reported to cause prolongation of the QT interval and Torsades de Pointes (TdP) ventricular tachycardia in adults. We describe the case of an 11-year-old child treated with fluconazole who developed ventricular arrhythmia culminating in TdP. We discuss the possible roles played by genetic and environmental factors in this child's rhythm disturbances. After briefly summarizing similar cases from the adult literature, we outline the putative mechanism by which fluconazole may cause arrhythmia. This case should alert pediatricians to the possible risks of fluconazole use, especially in the presence of electrolyte abnormalities, diuretic use, therapy with other pro-arrhythmic agents, or suspicion of congenital Long-QT Syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17849073     DOI: 10.1007/s00246-007-9076-0

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  12 in total

1.  Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline.

Authors:  S T Dorsey; L A Biblo
Journal:  Am J Emerg Med       Date:  2000-03       Impact factor: 2.469

2.  Torsades de pointes upon fluconazole administration in a patient with acute myeloblastic leukemia.

Authors:  Hiro Tatetsu; Norio Asou; Miki Nakamura; Nobuyoshi Hanaoka; Fumihiko Matsuno; Kentaro Horikawa; Hiroaki Mitsuya
Journal:  Am J Hematol       Date:  2006-05       Impact factor: 10.047

3.  Blockade of HERG cardiac K+ current by antifungal drug miconazole.

Authors:  Kan Kikuchi; Toshihisa Nagatomo; Haruhiko Abe; Kazunobu Kawakami; Henry J Duff; Jonathan C Makielski; Craig T January; Yasuhide Nakashima
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

4.  Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.

Authors:  I Splawski; J Shen; K W Timothy; M H Lehmann; S Priori; J L Robinson; A J Moss; P J Schwartz; J A Towbin; G M Vincent; M T Keating
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

5.  Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.

Authors:  Ping Yang; Hideaki Kanki; Benoit Drolet; Tao Yang; Jian Wei; Prakash C Viswanathan; Stefan H Hohnloser; Wataru Shimizu; Peter J Schwartz; Marshall Stanton; Katherine T Murray; Kris Norris; Alfred L George; Dan M Roden
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

6.  Dramatic inhibition of amiodarone metabolism induced by grapefruit juice.

Authors:  C C Libersa; S A Brique; K B Motte; J F Caron; L M Guédon-Moreau; L Humbert; A Vincent; P Devos; M A Lhermitte
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

7.  Fluconazole- and levofloxacin-induced torsades de pointes in an intensive care unit patient.

Authors:  Pritesh J Gandhi; Pearl A Menezes; Hien T Vu; Amy L Rivera; Karthik Ramaswamy
Journal:  Am J Health Syst Pharm       Date:  2003-12-01       Impact factor: 2.637

8.  Inhibition of the HERG K+ channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656.

Authors:  John M Ridley; James T Milnes; Rona S Duncan; Mark J McPate; Andrew F James; Harry J Witchel; Jules C Hancox
Journal:  FEBS Lett       Date:  2006-03-07       Impact factor: 4.124

Review 9.  Probable case of torsades de pointes induced by fluconazole.

Authors:  Minou Khazan; A Scott Mathis
Journal:  Pharmacotherapy       Date:  2002-12       Impact factor: 4.705

10.  Low penetrance in the long-QT syndrome: clinical impact.

Authors:  S G Priori; C Napolitano; P J Schwartz
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

View more
  2 in total

Review 1.  Triazole antifungal agents in invasive fungal infections: a comparative review.

Authors:  Cornelia Lass-Flörl
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

Review 2.  Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms.

Authors:  Gerrit Frommeyer; Lars Eckardt
Journal:  Nat Rev Cardiol       Date:  2015-07-21       Impact factor: 32.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.